Aerobiotix: Raises $25M in Growth Equity Financing
Aerobiotix, a Miamisburg, Ohio-based global medical company, raised $25m in equity financing
The round was led by Vivo Capital with participation from Asahi Kasei Ventures
The company also intends to use the funds to accelerate sales, marketing, and new product development
Aerobiotix also makes airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long term care and office based settings
The company’s infection control products have used to support thousands of procedures across multiple surgical specialty disciplines and in over 175 hospitals and multiple long-term care facilities
Aerobiotix has developed a novel suite of FDA 510(k) cleared hospital-based air decontamination products and its devices supported by multiple peer-reviewed research studies
